| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 03/20/2002 | CN1341095A Amide compounds for potentiation of cholinergic activity |
| 03/20/2002 | CN1341094A Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/20/2002 | CN1340499A Preparation method for amide |
| 03/19/2002 | US6359175 Cosmetic composition comprising an amide and novel amides |
| 03/19/2002 | US6359151 Use as pesticides. |
| 03/19/2002 | US6359008 Improved bioavailability of drugs and nutrients by permeabilizing cell membranes of organisms, in particular animals and fish; preferably contain a long chain alkyl or alkenyl group, such as a palmitoyl or oleate group |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | CA2134560C Anti-obesity drugs |
| 03/14/2002 | WO2002020464A2 Benzene tricarboxylic acid amides as insulin receptor activators |
| 03/14/2002 | WO2002020463A2 Fxr modulators |
| 03/14/2002 | WO2001060781A3 Diphenyl compounds, formulations and uses thereof |
| 03/14/2002 | WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | US20020032348 Bactericides; reacting imine, carbamate, ester, amide and epoxide derivatives |
| 03/14/2002 | US20020032341 Primary alkanolamides |
| 03/14/2002 | US20020032339 Aryl borates |
| 03/14/2002 | US20020032333 Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide |
| 03/14/2002 | US20020032218 Substituted stilbenes as glucose uptake enhancers |
| 03/14/2002 | US20020032210 Chloride channel blockers; useful in the treatment of sickle cell anaemia, brain edema following iscaemia or tumors, diarrhea, hypertension, bone metabolic disorders, osteoclast associated disoders; substituted biphenyl containing nitrogen |
| 03/14/2002 | CA2421581A1 Benzene tricarboxylic acid amides as insulin receptor activators |
| 03/13/2002 | EP1186613A1 New reagent for labelling nucleic acids |
| 03/13/2002 | EP1186305A1 New brominated compounds as contrast media for X-ray mammography |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP0975219B1 Fungicide active substance combinations |
| 03/13/2002 | EP0828704B1 Methods of making (s)-3-(aminomethyl)-5-methylhexanoic acid |
| 03/13/2002 | CN1340043A Phenylalaninol derivatives |
| 03/13/2002 | CN1080719C Substituted 1H-3-aryl-pyrrolidine-2,4-diones derivatives |
| 03/12/2002 | US6355838 Amide ester nitrates for crosslinking polymers |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/07/2002 | WO2002018328A1 Process for reacting carboxylic acids and esters |
| 03/07/2002 | WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018322A1 Process for the production of crystals of a benzoic acid derivative |
| 03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018320A2 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 03/07/2002 | WO2002018318A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 03/07/2002 | WO2002018035A2 Liquid membrane separation of enantiomers |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | US20020028970 Oxidizing a diamidodiol to form a diacid followed by coupling with an aryl diamine |
| 03/07/2002 | US20020028969 Reacting nitrile compounds with sulfate compounds in diol or triol solvent |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/07/2002 | US20020028833 Aryl alkenamides derivatives as mcp-1 antagonists |
| 03/07/2002 | US20020028799 Using protease and phospodiesterase inhibitor |
| 03/07/2002 | US20020028250 Carbon-substituted diketopiperazine delivery systems |
| 03/07/2002 | CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | CA2383855A1 Dyes for keratin fibers, the dyes containing n-benzyl-p-phenylenediamine derivatives and novel n-benzyl-p-phenylenediamine derivatives |
| 03/06/2002 | EP1184367A1 Amide derivatives |
| 03/06/2002 | EP1184366A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
| 03/06/2002 | EP1183317A2 Process for the preparation of herbicidal derivatives |
| 03/06/2002 | EP1183240A1 Beta2-adrenoceptor agonists |
| 03/06/2002 | EP1183074A1 Substituted biaryl ether compounds |
| 03/06/2002 | CN1080251C Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient and intermediate compound for use inproduct of said dihalopropene compounds |
| 03/05/2002 | US6353128 For treatment of conditions such as septic shock. |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353105 Inhibitors of 5-hydroxy-tryptamine reuptake of a monoamine transporter; analogs of cocaine; |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 03/05/2002 | US6353022 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | CA2050465C Cyclohexenol derivatives |
| 02/28/2002 | WO2002016313A2 Integrin receptor inhibitors |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2002015959A2 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015692A1 Composition having insect repellent characteristics |
| 02/28/2002 | WO2001072690A3 Method for producing n-butyryl-4-amino-3-methyl-methyl benzoate and the novel compound n-(4-bromine-2-methylphenyl)-butanamide |
| 02/28/2002 | WO2001023354A3 Trifluoromethyl-substituted spirocyclic ketoenols and use thereof as pesticides and herbicides |
| 02/28/2002 | US20020025949 Anti-epileptogenic agents |
| 02/28/2002 | US20020025401 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 02/28/2002 | DE10040726A1 Cycloaliphatisch-aromatische Diphosphine und ihre Verwendung in der Katalyse Cycloaliphatic-aromatic diphosphines and their use in catalysis |
| 02/28/2002 | CA2419580A1 Integrin receptor inhibitors |
| 02/27/2002 | EP1182191A1 Method for making amides |
| 02/27/2002 | EP1181267A1 Halogen compounds |
| 02/27/2002 | EP1181266A1 Squaric acid derivatives as cell adhesion molecules |
| 02/27/2002 | CN1079788C Amide derivatives and their therapeutic use |
| 02/26/2002 | US6350913 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
| 02/26/2002 | US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
| 02/26/2002 | US6350889 Oligomers of diacids, diols, aminoalcohols |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/26/2002 | CA2199568C Multifunctional vinyl cyclopropane derivatives |
| 02/26/2002 | CA2037731C Ethylenically unsaturated compounds |
| 02/21/2002 | WO2002014330A1 Cycloaliphatic/aromatic diphosphines and use thereof in catalysis |
| 02/21/2002 | WO2002014270A1 New amidino derivatives and their use as thrombin inhibitors |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014262A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | WO2002014259A1 Calcium receptor antagonists |
| 02/21/2002 | WO2001083423A3 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 02/21/2002 | DE10039247A1 Verfahren zur Herstellung von Carbonsäureamiden durch Oxidation von Aldehyden in Gegenwart von Aminen A process for the preparation of carboxamides by the oxidation of aldehydes in the presence of amines |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/20/2002 | EP1180006A2 Compositions and methods for their preparation from lepidium |
| 02/20/2002 | CN1336910A Novel 1,2-diphenyl-2-propen-1-one derivatives |
| 02/20/2002 | CN1079390C Propynyl or dienyl diaromatic compounds |
| 02/19/2002 | US6348626 Melting oxalic acid diester of aliphatic alcohol and same aliphatic alcohol, feed-mixing ammonia-containing gas to melt while stirring to produce oxamide and alcohol by-product, evaporating and removing alcohol forming wetted solid, drying |
| 02/19/2002 | US6348625 Treating corresponding carboxylic acid functional group with n,n-diethyl-1,1,2,3,3,3-hexafluoropropylamine followed by ammonia |
| 02/19/2002 | US6348614 Aminobutyric acid fungicides |
| 02/19/2002 | US6348498 Analgesics and cephalins |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/19/2002 | CA2165118C Cosmetic or dermatologic composition containing a ceramide mixture; use thereof for skin moisturizing |
| 02/14/2002 | WO2002012253A1 Use of chiral diphosphines as optically active ligands |